These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2577412)

  • 21. Beta-2 microglobulin removal during continuous ambulatory peritoneal dialysis (CAPD).
    Lysaght MJ; Pollock CA; Moran JE; Ibels LS; Farrell PC
    Perit Dial Int; 1989; 9(1):29-35. PubMed ID: 2488177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
    Grzegorzewska AE; Leander M; Mariak I
    Adv Perit Dial; 2002; 18():33-9. PubMed ID: 12402583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis.
    Akman S; van Westrhenen R; De Waart DR; Hiralall JK; Zweers MM; Krediet RT
    Adv Perit Dial; 2003; 19():24-7. PubMed ID: 14763029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
    Montenegro J; Saracho R; González O; Moina I; Martínez I
    Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ; Struijk DG; de Blok K; Krediet RT
    Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrafiltration failure and dialysate glucose in CAPD.
    Stegmayr B; Granbom L; Karlsson UM; Lindqvist B
    Adv Perit Dial; 1993; 9():62-4. PubMed ID: 8105964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of surface tension of dialysate depending on its composition in continuous ambulatory peritoneal dialysis.
    Jeleniewicz R; Majdan M; Buraczyńska K; Portala P; Majdan M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):290-5. PubMed ID: 12898852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
    Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
    J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term increase of glucose concentration in PDS results in extensive removal and high glycation level of vital proteins during continuous ambulatory peritoneal dialysis.
    Pešić I; Dihazi GH; Müller GA; Jahn O; Hoffmann M; Eltoweissy M; Koziolek M; Dihazi H
    Nephrol Dial Transplant; 2011 Aug; 26(8):2674-83. PubMed ID: 21285129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equilibration of peritoneal dialysis solutions during long-dwell exchanges.
    Nolph KD; Twardowski ZJ; Popovich RP; Rubin J
    J Lab Clin Med; 1979 Feb; 93(2):246-56. PubMed ID: 429837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis.
    Opatrný K; Opatrná S; Vít L; Opatrný K
    Am J Nephrol; 1998; 18(3):186-92. PubMed ID: 9627033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patients.
    Carozzi S; Nasini G; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    ASAIO Trans; 1990; 36(3):M369-71. PubMed ID: 2174686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal study of proteins in plasma and dialysate during continuous ambulatory peritoneal dialysis (CAPD).
    Young GA; Taylor A; Kendall S; Brownjohn AM
    Perit Dial Int; 1990; 10(4):257-61. PubMed ID: 2096924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choline levels in human peritoneal dialysate.
    Hjelle JT; Welch MH; Pavlina TM; Webb LE; Mockler D; Miller MA; Steidley KR; Olsson PJ; Horvath FJ; Mahon L
    Adv Perit Dial; 1992; 8():30-2. PubMed ID: 1361811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis.
    Reddingius RE; Schröder CH; Daha MR; Willems HL; Koster AM; Monnens LA
    Perit Dial Int; 1995; 15(1):49-53. PubMed ID: 7537541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-2 microglobulin in patients on peritoneal dialysis and hemodialysis.
    Scalamogna A; Imbasciati E; De Vecchi A; Castelnovo C; Pagliari B; De Cristofaro V; Ponticelli C
    Perit Dial Int; 1989; 9(1):37-40. PubMed ID: 2488178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of low calcium peritoneal dialysate.
    Kawanishi H; Tsuchiya T; Namba S; Takahashi N; Toyota T; Fukuma K; Kawai T
    ASAIO Trans; 1991; 37(3):M404-6. PubMed ID: 1751210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation between clearances of small and middle molecules in incremental peritoneal dialysis.
    Kim DJ; Do JH; Huh W; Kim YG; Oh HY
    Perit Dial Int; 2001; 21(5):462-6. PubMed ID: 11757829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cystatin C and Beta-2-microglobulin kinetics in children on maintenance hemodialysis.
    Marsenic O; Wierenga A; Wilson DR; Anderson M; Shrivastava T; Simon GA; Beck AM; Swanson TJ; Studnicka K; Elberg D; Singh NS; Couloures K; Henry D; Turman MA
    Hemodial Int; 2013 Oct; 17 Suppl 1():S11-6. PubMed ID: 24134324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.